NEW YORK (GenomeWeb) – Finnish molecular diagnostics firm Mobidiag today announced that its Amplidiag qPCR-based stool test for detection of Helicobacter pylori and clarithromycin resistance has received CE-IVD marking.

The test, part of the firm's Amplidiag line of gastric pathogen tests, will be immediately available throughout Europe.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.